Major shareholder announcement - BlackRock, Inc.

16 September 2026
ANNOUNCEMENT NO. 315

Major shareholder announcement - BlackRock, Inc.         

Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock, Inc., on 14 September 2026, increased its total holding in ChemoMetec A/S to 15.00%, and that the holding thus has reached the 15 per cent limit in Section 38 of the Capital Markets Act.

Additional information

Martin Helbo Behrens, CEO
Tel.: (+45) 81 10 06 80 

Phillip Massie Price, CFO
Tel.: (+45) 81 10 06 80 

About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements.
ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com.

You May Also Be Interested In

• Chrysalis Health and Curaechoice Join Forces to Address Cost and Access Barriers to Mental Health Care
• Latest ETH News: Ethereum’s Climb Toward $5,000 and Apeing’s Crypto Presale Advances to Stage 5 With $0.00055 Pricing
• Purpose Investments Inc. Announces Final September 2026 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fu